These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 30222875)

  • 1. Image Gallery: Amyloidoma secondary to insulin injection.
    John I
    Br J Dermatol; 2018 Sep; 179(3):e131. PubMed ID: 30222875
    [No Abstract]   [Full Text] [Related]  

  • 2. Localized insulin-dependent amyloidosis with scar-tissue formation.
    Damm F; Goerdt S; Schmieder A
    J Am Acad Dermatol; 2014 Oct; 71(4):e160-2. PubMed ID: 25219749
    [No Abstract]   [Full Text] [Related]  

  • 3. Examination of insulin injection sites: an unexpected finding of localized amyloidosis.
    Swift B
    Diabet Med; 2002 Oct; 19(10):881-2. PubMed ID: 12358880
    [No Abstract]   [Full Text] [Related]  

  • 4. [Diabetic with multiple small hematomas. Wrong injection technique].
    Harsch IA
    MMW Fortschr Med; 2011 May; 153(19):5. PubMed ID: 21612086
    [No Abstract]   [Full Text] [Related]  

  • 5. Nodular amyloidosis in a diabetic patient with frequent hypoglycemia: sequelae of repeatedly injecting insulin without site rotation.
    Endo JO; Röcken C; Lamb S; Harris RM; Bowen AR
    J Am Acad Dermatol; 2010 Dec; 63(6):e113-4. PubMed ID: 21093656
    [No Abstract]   [Full Text] [Related]  

  • 6. [Insulin application techniques in adult patients with diabetes].
    Pelcl T; Prázný M
    Vnitr Lek; 2016; 62(6):486-90. PubMed ID: 27485848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Localized amyloidosis at the site of repeated insulin injection in a patient with type 2 diabetes.
    Okamura S; Hayashino Y; Kore-Eda S; Tsujii S
    Diabetes Care; 2013 Dec; 36(12):e200. PubMed ID: 24265372
    [No Abstract]   [Full Text] [Related]  

  • 8. Coexistence of insulin-derived amyloidosis and an overlying acanthosis nigricans-like lesion at the site of insulin injection.
    Kudo-Watanuki S; Kurihara E; Yamamoto K; Mukai K; Chen KR
    Clin Exp Dermatol; 2013 Jan; 38(1):25-9. PubMed ID: 22924529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphoblastic lymphoma arising at the insulin injection sites in a child with type 1 diabetes mellitus.
    Wang JD; Chang TK; Shu SG
    J Pediatr; 2010 Dec; 157(6):1043-1043.e1. PubMed ID: 20547397
    [No Abstract]   [Full Text] [Related]  

  • 10. Insulin-derived amyloidosis without a palpable mass at the insulin injection site: A report of two cases.
    Nagase T; Iwaya K; Kogure K; Zako T; Misumi Y; Kikuchi M; Matsumoto K; Noritake M; Kawachi Y; Kobayashi M; Ando Y; Katsura Y
    J Diabetes Investig; 2020 Jul; 11(4):1002-1005. PubMed ID: 31867887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CT of dystrophic calcification in subcutaneous soft tissues secondary to chronic insulin injection.
    Ullman HR; Dasgupta A; Recht M; Cash JM
    J Comput Assist Tomogr; 1995; 19(4):657-9. PubMed ID: 7622706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Images in clinical medicine. Injection-site lipoatrophy.
    Sackey AH
    N Engl J Med; 2009 Nov; 361(19):e41. PubMed ID: 19890122
    [No Abstract]   [Full Text] [Related]  

  • 13. Exogenous insulin-derived acanthosis nigricans: could it be a cause of increased insulin requirement?
    Dhingra M; Garg G; Gupta M; Khurana U; Thami GP
    Dermatol Online J; 2013 Jan; 19(1):9. PubMed ID: 23374951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Localized cutaneous amyloid at an insulin injection site.
    Lonsdale-Eccles AA; Gonda P; Gilbertson JA; Haworth AE
    Clin Exp Dermatol; 2009 Dec; 34(8):e1027-8. PubMed ID: 20055830
    [No Abstract]   [Full Text] [Related]  

  • 15. Arguments against the use of inhaled insulin.
    Hirsch IB
    Diabetes Technol Ther; 2007 Jun; 9 Suppl 1():S111-4. PubMed ID: 17563299
    [No Abstract]   [Full Text] [Related]  

  • 16. Current insight in the localized insulin-derived amyloidosis (LIDA): clinico-pathological characteristics and differential diagnosis.
    Ansari AM; Osmani L; Matsangos AE; Li QK
    Pathol Res Pract; 2017 Oct; 213(10):1237-1241. PubMed ID: 28935176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attenuation of subcutaneous insulin induced amyloid mass in vivo using Lumbrokinase and Serratiopeptidase.
    Metkar SK; Girigoswami A; Vijayashree R; Girigoswami K
    Int J Biol Macromol; 2020 Nov; 163():128-134. PubMed ID: 32615214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin allergy and insulin resistance.
    Goldfine AB; Kahn CR
    Curr Ther Endocrinol Metab; 1994; 5():461-4. PubMed ID: 7704774
    [No Abstract]   [Full Text] [Related]  

  • 19. Physical signs for the general dental practitioner. Case 74. Lipohypertrophy.
    Bain S
    Dent Update; 2010 May; 37(4):268. PubMed ID: 20527502
    [No Abstract]   [Full Text] [Related]  

  • 20. Nodular amyloidosis at the sites of insulin injections.
    Bernárdez C; Schärer L; Molina-Ruiz AM; Requena L
    J Cutan Pathol; 2015 Jul; 42(7):496-502. PubMed ID: 25953111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.